Symposium

mRNA Vaccine Design and Delivery to Immune Cells

In honor of:
Eric Huang
Katalin Karikó
Uğur Şahin
Özlem Türeci
Drew Weissman

for pioneering work leading to the discovery and development of mRNA vaccines.

Opening Remarks
George Q. Daley, MD, PhD
Dean of the Faculty of Medicine, Harvard University
Caroline Shields Walker Professor of Medicine

Moderator
Shiv Pillai, MD, PhD
Professor of Medicine and Health Sciences and Technology
Ragon Institute of MGH, MIT and Harvard

Presentations
Katalin Karikó, PhD
Senior Vice President, BioNTech SE, and Adjunct Professor of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania
Developing mRNA for Therapy

Drew Weissman, MD, PhD
Roberts Family Professor in Vaccine Research, Perelman School of Medicine at the University of Pennsylvania
Nucleoside-Modified mRNA-LNP Therapeutics

Uğur Şahin, MD
Co-founder and Chief Executive Officer, BioNTech SE, and Helmholtz Professor for mRNA Cancer Immunotherapies, German Cancer Research Center in the Helmholtz Institute Mainz; and Professor, University Medical Center of the Johannes Gutenberg University Mainz
mRNA Cancer Vaccines and Immunotherapies

Özlem Türeci, MD
Co-founder and Chief Medical Officer, BioNTech SE, and Helmholtz Professor for Personalized Cancer Immunotherapies, German Cancer Research Center in the Helmholtz Institute Mainz
Project Lightspeed: Developing a COVID-19 mRNA Vaccine

Eric Huang, PhD
General Manager and Chief Scientific Officer, Moderna Genomics
Moderna’s mRNA Platform and Vaccines: Our Reflection and Journey to Today

Location:
Joseph B. Martin Conference Center, New Research Building
Harvard Medical School
77 Avenue Louis Pasteur, Boston

Open to the Public. Seating is on a first come, first served basis.
The symposium will also be simulcast at:
https://harvard.zoom.us/webinar/register/WN_a78abPasS_667YuVoq944Q